Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration

Molecular Genetics and Genomics

Volumn 283, Issue 5, 2010, Pages 485-492

  Li, Tingting ^a,b   Wan, Bingbing ^c   Huang, Jian ^d   Zhang, Xuegong ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b TSINGHUA UNIVERSITY   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^d NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Functional preference; Hepatocellular carcinoma; Liver development; Liver regeneration; Microarray; Transcriptional regulation

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; HEPATOCYTE NUCLEAR FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1BETA; MAX PROTEIN; MYC PROTEIN; PYRUVATE DEHYDROGENASE KINASE 4; SMAD PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR TBX5; TUMOR SUPPRESSOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER REGENERATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; CANCER STAGING; CLUSTER ANALYSIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; PRENATAL DEVELOPMENT; PRINCIPAL COMPONENT ANALYSIS; TIME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM STAGING; PRINCIPAL COMPONENT ANALYSIS; TIME FACTORS;

EID: 77951640416     PISSN: 16174615     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00438-010-0530-y     Document Type: Article

References (34)

1. Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R (2008) S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 8:243-252
2. Castillo-Davis CI, Hartl DL (2003) GeneMerge-post-genomic analysis, data mining, and hypothesis testing. Bioinformatics 19:891-892
3. Coulouarn C, Derambure C, Lefebvre G, Daveau R, Hiron M, Scotte M, Francois A, Daveau M, Salier JP (2005) Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-totumor transition. J Hepatol 42:860-869
4. Dai M, Wang P, Boyd AD et al (2005) Evolving gene/transcript deWnitions signiWcantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175
5. Damdinsuren B, Nagano H, Kondo M et al (2005) Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dediVerentiation. Int J Oncol 26:319-327
6. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
7. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D (2005) Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11:5146-5152
8. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
9. Jin H, Pan Y, He L et al (2007) p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res 5:423-433
10. Kaiser S, Park YK, Franklin JL et al (2007) Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8:R131
11. Kelley-Loughnane N, Sabla GE, Ley-Ebert C, Aronow BJ, Bezerra JA (2002) Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology 35:525-534
12. Krones-Herzig A, Adamson E, Mercola D (2003) Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proc Natl Acad Sci USA 100:3233-3238
13. Krones-Herzig A, Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson ED, Mercola D (2005) Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 65:5133-5143
14. Leukert N, Vogl T, Strupat K, Reichelt R, Sorg C, Roth J (2006) Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol 359:961-972
15. Li T, Huang J, Jiang Y, Zeng Y, He F, Zhang MQ, Han Z, Zhang X (2009) Multi-stage analysis of gene expression and transcription regulation in C57/B6 mouse liver development. Genomics 93:235-242
16. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, Zhang J (2006) Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66:1311-1318
17. Mahner S, Baasch C, Schwarz J, Hein S, Wolber L, Janicke F, Milde-Langosch K (2008) C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer 99:1269-1275
18. Matys V, Fricke E, GeVers R et al (2003) TRANSFAC: transcriptional regulation, from patterns to proWles. Nucleic Acids Res 31:374-378
19. Moon A, Yong HY, Song JI et al (2008) Global gene expression pro-Wling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol Cancer Res 6:1544-1553
20. Naxerova K, Bult CJ, Peaston A, Fancher K, Knowles BB, Kasif S, Kohane IS (2008) Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers. Genome Biol 9:R108
21. Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knuchel R, Dahl E (2008) Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer 8:154
22. Otu HH, Naxerova K, Ho K, Can H, Nesbitt N, Libermann TA, Karp SJ (2007) Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem 282:11197-11204
23. Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P (2009) Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 69:2375-2383
24. Pouliot F, Blais A, Labrie C (2003) Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res 63:277-281
25. Roth J, Vogl T, Sorg C, Sunderkotter C (2003) Phagocyte-speciWc S100 proteins: a novel group of proinXammatory molecules. Trends Immunol 24:155-158
26. Salomaki HH, Sainio AO, Soderstrom M, Pakkanen S, Laine J, Jarvelainen HT (2008) DiVerential expression of decorin by human malignant and benign vascular tumors. J Histochem Cytochem 56:639-646
27. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding proWles. Nucleic Acids Res 32:D91-D94
28. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV (2006) Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 281:26408-26418
29. Smith AD, Sumazin P, Xuan Z, Zhang MQ (2006) DNA motifs in human and mouse proximal promoters predict tissue-speciWc expression. Proc Natl Acad Sci USA 103:6275-6280
30. Storey JD, Xiao W, Leek JT, Tompkins RG, Davis RW (2005) SigniWcance analysis of time course microarray experiments. Proc Natl Acad Sci USA 102:12837-12842
31. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346
32. Turovskaya O, Foell D, Sinha P et al (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29:2035-2043
33. Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Buchler MW, Friess H (2008) CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 259:209-217
34. Wurmbach E, Chen YB, Khitrov G et al (2007) Genome-wide molecular proWles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938-947